Refine by
Epitope Technology
13 companies found
Technologybased inSalt Lake City, UTAH (USA)
3Helix develops and markets a novel collagen targeting technology, providing scientists and clinicians with new tools to investigate collagen pathology and to develop diagnostics and therapeutics for diseases with high collagen remodeling ...
The collagen hybridizing peptide (CHP) is a novel and unique peptide that specifically binds unfolded collagen chains, bothin vitroand in vivo.[1,2,3] By sharing the Gly-X-Y repeating sequence of natural collagen, CHP has a strong capability to ...
Technologybased inSouth San Francisco, CALIFORNIA (USA)
Sutro Biopharma is a clinical stage company pioneering a compelling and unique way of discovering, developing and manufacturing therapeutics. Our focus is aimed primarily on next-generation cancer therapeutics – antibody drug conjugates, bispecific ...
Sutro’s cell-free expression technology provides a rapid and powerful platform for the discovery and development of next generation antibody-drug conjugates ...
Technologybased inRehovot, ISRAEL
Biolojic Design is committed to curing patients by designing and developing a pipeline of revolutionary therapeutics. Biolojic’s platform generates antibodies that bind to predefined epitopes, thus allowing for the design of specific functions: ...
Redefining What Antibodies Can Do: Biolojic’s platform generates antibodies that bind to predefined epitopes, thus allowing for the design of specific functions: agonism, antagonism and selective binding. The platform also ...
Technologybased inDaejeon, SOUTH KOREA
We are exploring sequence-based drug discovery and development, which is bypassing the need for 3D structure. ...
Epitope is a part of an antigenic protein consisting of a sequence of 8 to 15 amino acids that provide the immunogenicity of an antigen protein. Immune receptors such as TCR, BCR, and MHC of various immune cells including T cells, B ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
Immunotherapeutic cancer vaccines have generated a lot of interest from oncologists since it was discovered that immune activation can lead to a specific antitumor response.1 However, despite initial progress, most cancer vaccines have failed to ...
Technologybased inHayward, CALIFORNIA (USA)
We are a biotech startup in the San Francisco Bay Area founded in February 2017. We focus on developing complex antibodies with enhanced efficacy, safety, and manufacturability features against difficult-to-treat diseases including cancer, ...
Humanization percentage, CDR Immunogenicity, Antigen binding affinity, Antibody expression level, Aggregation potential, Antibody stability, ...
Technologybased inWoburn, MASSACHUSETTS (USA)
Founded in 2007, HUABIO is dedicated to developing curated, high-quality antibodies that advance innovation. We're passionate about the accuracy, efficiency, and consistency of our products. We devote our company mission to the disruption of an ...
These antibodies are actually a collection of immunoglobulin molecules that react against a specific antigen, each identifying a different epitope on an ...
Technologybased inHørsholm, DENMARK
We are an AI-immunology platform company decoding the human immune system to discover and develop novel immunotherapies for cancer and infectious diseases. We have developed our AI-immunology core technology to deeply understand the biological ...
RAVEN is our third proprietary AI platform that brings our unique, machine learning approach to vaccine design and development for viral diseases. RAVEN combines the essential AI tools from our PIONEER platform with structural bioinformatic tools ...
Technologybased inHennigsdorf, GERMANY
We are a biotechnology company, located with our headquarters in Hennigsdorf just outside Berlin and our production site in Berlin-Buch. Directions can be found here. We provide our customers with a range of products in the field of protein array ...
Technologybased inCarmel, INDIANA (USA)
Sword Diagnostics is a cutting-edge life sciences company created in response to the rapidly evolving needs of the research and pharmaceutical communities. Although researchers are discovering thousands of biomarkers associated with both healthy and ...
Utilizing our proprietary Sword Swift™ Method Development Process and Sword Swift™ Detection Reagents, our scientists can develop sensitive quantitative assays to measure the amounts of free or bound drug in preclinical or clinical ...
Technologybased inCambridge, UNITED KINGDOM
Based in Cambridge, one of Europe's largest bioscience hubs, Biorbyt has a simple yet challenging mission: to provide the best service to the global scientific community. We achieve this by collaborating with the world’s finest researchers and ...
Antibodies, also known as immunoglobulins (Ig), usually have a high affinity to a specific antigen, binding only to one epitope/binding site on an antigen. Monoclonal (Mab) or polyclonal (pAb) antibodies are used in scientific ...
Technologybased inCupertino, CALIFORNIA (USA)
Protein Metrics is led by a team with world-class expertise in business development, algorithm design, and software engineering grounded in fundamental understanding of protein science and biopharma ...
Technologybased inSão Paulo, BRAZIL
Celluris is the first company in Latin America to develop personalized treatment for cancer patients through CAR-T immunotherapy. This technique is based on the modification of the patient’s own cells into recognizing the tumor as a target, fighting ...
The Celluris’ novel solution, named RfuCAR, was engineering in order to respond some challenges addressed by clinical trials around the world. RfuCAR is a bispecific in tandem receptor CAR, that is composed by an antigen binding domain and ...